These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1217 related articles for article (PubMed ID: 6435538)
1. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma]. Jimbow K; Miura S; Ito Y; Kasuga T; Ito S Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538 [TBL] [Abstract][Full Text] [Related]
2. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway]. Jimbow K Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704 [TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy. Ito Y; Jimbow K Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807 [TBL] [Abstract][Full Text] [Related]
4. Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma. Jimbow K; Miura T; Ito S; Ishikawa K Pigment Cell Res; 1989; 2(1):34-9. PubMed ID: 2717528 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect. Miura S; Ueda T; Jimbow K; Ito S; Fujita K Arch Dermatol Res; 1987; 279(4):219-25. PubMed ID: 3674957 [TBL] [Abstract][Full Text] [Related]
6. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione. Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002 [TBL] [Abstract][Full Text] [Related]
7. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis. Menon IA; Haberman HF Acta Derm Venereol; 1978; 58(1):9-11. PubMed ID: 75646 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. Ito S; Kato T; Ishikawa K; Kasuga T; Jimbow K Biochem Pharmacol; 1987 Jun; 36(12):2007-11. PubMed ID: 3109434 [TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Gili A; Thomas PD; Ota M; Jimbow K Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635 [TBL] [Abstract][Full Text] [Related]
10. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol. Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol. Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K Biochem Pharmacol; 1998 Jun; 55(12):2023-9. PubMed ID: 9714323 [TBL] [Abstract][Full Text] [Related]
12. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative. Miura T; Jimbow K; Ito S Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652 [TBL] [Abstract][Full Text] [Related]
13. Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation. Jung H; Chung H; Chang SE; Choi S; Han IO; Kang DH; Oh ES Pigment Cell Melanoma Res; 2014 May; 27(3):387-97. PubMed ID: 24472179 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol. Ferguson J; Rogers PM; Kelland LR; Robins DJ Oncol Res; 2005; 15(2):87-94. PubMed ID: 16119006 [TBL] [Abstract][Full Text] [Related]
15. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth. Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of melanin synthesis by cystamine in human melanoma cells. Qiu L; Zhang M; Sturm RA; Gardiner B; Tonks I; Kay G; Parsons PG J Invest Dermatol; 2000 Jan; 114(1):21-7. PubMed ID: 10620110 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol. Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624 [TBL] [Abstract][Full Text] [Related]
18. Radicals and melanomas. Riley PA Philos Trans R Soc Lond B Biol Sci; 1985 Dec; 311(1152):679-89. PubMed ID: 2869525 [TBL] [Abstract][Full Text] [Related]
19. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma. Jimbow K; Iwashina T; Alena F; Yamada K; Pankovich J; Umemura T J Invest Dermatol; 1993 Feb; 100(2 Suppl):231S-238S. PubMed ID: 8433013 [TBL] [Abstract][Full Text] [Related]
20. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol. Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]